Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI ...

The global Pharmaceutical Lactose Market is poised for robust growth, projected to increase from USD 249.6 million in 2025 to ...

CPHI China has long been recognized as a premier platform for connecting the entire pharmaceutical supply chain, from active ...

Scale-up of the CDMO segment in FY26, is expected to contribute meaningfully to revenue growth and margin expansion, aided by ...

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed. FDA has granted an expanded Emergency Use Authorization to Pfizer and BioNTech’s COVID-19 ...

STAR-LLD is a continuous delivery lenalidomide (LLD) in development to expand and replace the standard-of-care for the most common blood cancers, multiple myeloma (MM), and chronic lymphocytic ...